Your browser doesn't support javascript.
loading
Preventing microalbuminuria with benazepril, valsartan, and benazepril-valsartan combination therapy in diabetic patients with high-normal albuminuria: A prospective, randomized, open-label, blinded endpoint (PROBE) study.
Ruggenenti, Piero; Cortinovis, Monica; Parvanova, Aneliya; Trillini, Matias; Iliev, Ilian P; Bossi, Antonio C; Belviso, Antonio; Aparicio, Maria C; Trevisan, Roberto; Rota, Stefano; Perna, Annalisa; Peracchi, Tobia; Rubis, Nadia; Martinetti, Davide; Prandini, Silvia; Gaspari, Flavio; Carrara, Fabiola; De Cosmo, Salvatore; Tonolo, Giancarlo; Mangili, Ruggero; Remuzzi, Giuseppe.
Afiliação
  • Ruggenenti P; Department of Renal Medicine, Clinical Research Center for Rare Diseases, "Aldo e Cele Daccò": Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Ranica, Bergamo, Italy.
  • Cortinovis M; Unit of Nephrology and Dialysis, Azienda Socio-Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy.
  • Parvanova A; Department of Renal Medicine, Clinical Research Center for Rare Diseases, "Aldo e Cele Daccò": Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Ranica, Bergamo, Italy.
  • Trillini M; Department of Renal Medicine, Clinical Research Center for Rare Diseases, "Aldo e Cele Daccò": Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Ranica, Bergamo, Italy.
  • Iliev IP; Department of Renal Medicine, Clinical Research Center for Rare Diseases, "Aldo e Cele Daccò": Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Ranica, Bergamo, Italy.
  • Bossi AC; Department of Renal Medicine, Clinical Research Center for Rare Diseases, "Aldo e Cele Daccò": Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Ranica, Bergamo, Italy.
  • Belviso A; Unit of Diabetology and Metabolic Diseases, Azienda Socio-Sanitaria Territoriale Bergamo Ovest, Treviglio-Caravaggio-Romano, Bergamo, Italy.
  • Aparicio MC; Poliambulatorio extra-ospedaliero, Azienda Socio-Sanitaria Territoriale Bergamo Ovest, Brembate di Sopra, Bergamo, Italy.
  • Trevisan R; Department of Renal Medicine, Clinical Research Center for Rare Diseases, "Aldo e Cele Daccò": Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Ranica, Bergamo, Italy.
  • Rota S; Unit of Diabetology and Endocrinology, Azienda Socio-Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy.
  • Perna A; Unit of Nephrology and Dialysis, Azienda Socio-Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy.
  • Peracchi T; Department of Renal Medicine, Clinical Research Center for Rare Diseases, "Aldo e Cele Daccò": Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Ranica, Bergamo, Italy.
  • Rubis N; Department of Renal Medicine, Clinical Research Center for Rare Diseases, "Aldo e Cele Daccò": Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Ranica, Bergamo, Italy.
  • Martinetti D; Department of Renal Medicine, Clinical Research Center for Rare Diseases, "Aldo e Cele Daccò": Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Ranica, Bergamo, Italy.
  • Prandini S; Department of Renal Medicine, Clinical Research Center for Rare Diseases, "Aldo e Cele Daccò": Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Ranica, Bergamo, Italy.
  • Gaspari F; Department of Renal Medicine, Clinical Research Center for Rare Diseases, "Aldo e Cele Daccò": Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Ranica, Bergamo, Italy.
  • Carrara F; Department of Renal Medicine, Clinical Research Center for Rare Diseases, "Aldo e Cele Daccò": Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Ranica, Bergamo, Italy.
  • De Cosmo S; Department of Renal Medicine, Clinical Research Center for Rare Diseases, "Aldo e Cele Daccò": Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Ranica, Bergamo, Italy.
  • Tonolo G; Unit of Internal Medicine, Research Hospital "Casa Sollievo della Sofferenza", San Giovanni Rotondo, Foggia, Italy.
  • Mangili R; SC Diabetologia Aziendale ASL 2 Olbia, San Giovanni di Dio Hospital, Olbia, Italy.
  • Remuzzi G; Azienda Socio-Sanitaria Territoriale Bergamo Est, Seriate, Bergamo, Italy.
PLoS Med ; 18(7): e1003691, 2021 07.
Article em En | MEDLINE | ID: mdl-34260595
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Benzazepinas / Inibidores da Enzima Conversora de Angiotensina / Bloqueadores do Receptor Tipo 1 de Angiotensina II / Diabetes Mellitus Tipo 2 / Albuminúria / Valsartana Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Benzazepinas / Inibidores da Enzima Conversora de Angiotensina / Bloqueadores do Receptor Tipo 1 de Angiotensina II / Diabetes Mellitus Tipo 2 / Albuminúria / Valsartana Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article